Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-064897

Chief Executive Officer acquired 40,510 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2020-12-18 Option exercise +12,236 $4.75 $58,121 2,517,473 D
Anzalone Christopher Richard Chief Executive Officer 2020-12-18 Option exercise +28,274 $6.15 $173,885 2,545,747 D
Derivatives
Anzalone Christopher Richard Chief Executive Officer 2020-12-18 Option exercise · Common Stock (right to buy) −12,236 828,307 D
Anzalone Christopher Richard Chief Executive Officer 2020-12-18 Option exercise · Common Stock (right to buy) −28,274 800,033 D
Loading xslF345X03/doc4.xml…